Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance

Affiliations

• ¹ Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
• ² Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
• ³ College of Chemical Engineering, Shijiazhuang University, Shijiazhuang, Hebei, China.
• ⁴ Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. jj_zcy@vip.163.com.
• ⁵ Department of Biotherapy, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, China. drmaxuelei@gmail.com.
• ⁶ Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. shihb@scu.edu.cn.